中国≥75岁ACS患者他汀使用与LDL-C水平现状
基于CCC-ACS全国150家三级医院登记数据,纳入2014年11月至2017年6月共10 899例≥75岁ACS住院患者,按ASCVD病史分组分析院前他汀使用、入院LDL-C水平及出院他汀处方情况。结果显示有ASCVD病史者院前他汀使用不足、多数未达LDL-C目标,而无ASCVD病史者过半入院LDL-C已达理想水平。
要点
- 有ASCVD病史的≥75岁ACS患者院前他汀服用率仅33.9%,LDL-C<1.8 mmol/L者仅24.7%。
- 无ASCVD病史者院前他汀服用率12.7%,51.7%入院LDL-C<2.6 mmol/L。
- 无禁忌证患者出院他汀处方率达91.2%,院内二级预防衔接较好。
核心结论
- ≥75岁ASCVD复发患者院前他汀使用不足,多数复发时LDL-C未达推荐标准。
- 无ASCVD病史的老年ACS患者过半入院LDL-C处于理想水平,老年一级预防LDL-C目标值需进一步研究。
研究设计与样本
- 基于中国心血管疾病医疗质量改善项目(CCC-ACS),全国150家三级医院参与的登记研究。
- 纳入2014年11月至2017年6月≥75岁ACS住院患者共10 899例,按ASCVD病史分为两组。
- 中位年龄79岁,男性6 397例(58.7%)。
主要发现
- 有ASCVD病史组3 028例,院前他汀服用33.9%(1 028例),入院LDL-C为(2.4±0.9)mmol/L,24.7%(747例)LDL-C<1.8 mmol/L。
- 无ASCVD病史组7 871例,院前他汀服用12.7%(996例),入院LDL-C为(2.6±0.9)mmol/L,51.7%(4 072例)LDL-C<2.6 mmol/L。
- 出院时无他汀禁忌证患者中91.2%(9 524/10 488)接受他汀处方。
关键数值与推荐
- 有ASCVD病史组LDL-C<1.8 mmol/L者占24.7%(747例)。
- 无ASCVD病史组LDL-C<2.6 mmol/L者占51.7%(4 072例)。
临床怎么用
- 对≥75岁ASCVD病史患者应关注院前他汀使用与LDL-C达标情况,强化二级预防。
- 出院环节他汀处方率较高,可借此衔接院外长期管理。
- 老年无ASCVD病史者一级预防LDL-C目标尚存争议,需个体化评估。
局限性
- 原文摘要未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To assess the use of statins and low-density lipoprotein cholesterol (LDL-C) levels at admission in hospitalized patients aged 75 years and older with acute coronary syndrome (ACS) in China. Methods: Data used in this study derived from the Improving Care for Cardiovascular Disease in China (CCC)-ACS project, a nationwide registry with 150 tertiary hospitals reporting details of clinical information of ACS patients. This study enrolled patients 75 years and older with ACS in CCC-ACS project from November 2014 to June 2017. Patients were divided into two groups according to the history of atherosclerotic cardiovascular disease (ASCVD). Pre-hospital statin use, LDL-C levels at admission and prescription of statins at discharge were reported. Results: A total of 10 899 patients 75 years and older with ACS were enrolled. The median age was 79 years and 58.7% (6 397 cases) were male. Among patients with history of ASCVD, 33.9% (1 028 cases) of them received statins before hospitalization. Among patients without history of ASCVD, 12.7% (996/7 871) received statins before hospitalization. The mean level of LDL-C was (2.4±0.9) mmol/L and LDL-C was <1.8 mmol/L in 24.7% (747 cases) of patients with history of ASCVD. The mean level of LDL-C was (2.6±0.9) mmol/L and LDL-C was <2.6 mmol/L in 51.7% (4 072 cases) of patients without history of ASCVD. At discharge, 91.2% (9 524/10 488) of patients were prescribed with statins in patients without contraindications for statin. Conclusion: In elderly patients with recurrent ASCVD, there was an inadequate statin use before hospitalization and most patients did not reach the LDL-C target level when they had the recurrent events. In the elderly ACS patients without history of ASCVD, more than half of the patients had an ideal LDL-C level. It seems that ideal LDL-C level for primary prevention of ACS in elderly people needs to be reevaluated with further studies. 目的: 了解中国年龄≥75岁急性冠状动脉综合征(ACS)住院患者他汀类药物使用现状及入院时低密度脂蛋白胆固醇(LDL-C)水平。 方法: 本研究基于"中国心血管疾病医疗质量改善项目"。该项目在全国150家三级医院入选ACS住院患者,系统收集患者临床相关信息。本研究纳入该项目自2014年11月至2017年6月期间收集的年龄≥75岁的ACS患者,根据是否合并动脉粥样硬化性心血管疾病(ASCVD)病史分为有ASCVD病史组和无ASCVD病史组,分析其院前他汀类药物服用比例、入院时LDL-C水平及出院时接受他汀处方的比例。 结果: 共10 899例≥75岁的ACS住院患者纳入本研究,年龄79(77,83)岁,男性6 397例(58.7%)。在有ASCVD病史组(3 028例)中,33.9%(1 028例)的患者院前服用他汀;在无ASCVD病史组(7 871例)中,12.7%(996例)的患者院前服用他汀。有ASCVD病史组入院时LDL-C水平为(2.4±0.9)mmol/L,24.7%(747例)的患者LDL-C<1.8 mmol/L;无ASCVD病史组入院时LDL-C水平为(2.6±0.9)mmol/L,51.7%(4 072例)的患者LDL-C<2.6 mmol/L。在出院存活且无他汀使用禁忌证的患者中,91.2%(9 524/10 488)的患者出院时接受了他汀处方。 结论: ≥75岁老年ASCVD复发患者中,他汀类药物服用率较低,大部分患者本次复发入院时LDL-C水平未达到推荐标准;而既往无ASCVD病史的老年ACS患者中,入院时LDL-C在理想水平者超过50%,老年人群一级预防的LDL-C目标值值得进一步研究。.
引用
- Xing YY, Liu J, Liu J, et al. [Statin use and low-density lipoprotein cholesterol levels in patients aged 75 years and older with acute coronary syndrome in China]. Zhonghua Xin Xue Guan Bing Za Zhi. 2019. PMID: 31142078. doi:10.3760/cma.j.issn.0253-3758.2019.05.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。